Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Pharmaceutical angiogenic composition including a microRNA-382 activator

Pharmaceutical angiogenic composition including a microRNA-382 activator

US Patent 9051620 · Granted Jun 9, 2015

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Composition for treating cancer or inhibiting cancer metastasis, including TFG o2023
Method for treating breast cancer by targeting breast cancer stem cell2017
Pharmaceutical composition comprising MicroRNA-30B, MicroRNA-133A, or MicroRNA-22016
Pharmaceutical anti-angiogenic composition including a MicroRNA-382 inhibitor2015